Basophil activation by concanavalin A: characteristics of the reaction.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001491:Basophils / Q000187:drug effects* / Q000276:immunology; D001772:Blood Cell Count; D001792:Blood Platelets / Q000276:immunology; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium; D002241:Carbohydrates / Q000494:pharmacology; D002743:Chlorphenesin / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology*; D000242:Cyclic AMP / Q000378:metabolism; D003903:Deuterium / Q000494:pharmacology; D004049:Diethylcarbamazine / Q000494:pharmacology; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology; D008274:Magnesium; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D051379:Mice; D011817:Rabbits; D051381:Rats
D002241:Carbohydrates; D003208:Concanavalin A; D000628:Aminophylline; D003994:Bucladesine; D003903:Deuterium; D000242:Cyclic AMP; D008274:Magnesium; D002743:Chlorphenesin; D007545:Isoproterenol; D002118:Calcium; D004049:Diethylcarbamazine